-
-
-
-
-
-
-
Deutsche Bank Defends Dendreon (DNDN) Despite Strong Zytiga Data; Maintains Buy
-
-
-
-
-
-
-
Baird Reiterates a 'Neutral' on Dendreon (DNDN); Behind Strong Pre-Release: New Med/Onc Survey a Mixed Bag for Provenge
-
-
-
-
-
-
-
Morning Movers 08/04: (WWWW) (SRDX) (ATSG) (LHCG) Higher; (DNDN) (ENTR) (NCIT) (GTIV) (CLWR) Lower
-
-
-
-
-
-
-
Dendreon (DNDN) Higher After Positive Provenge Reimbursement News
-
-
-
-
-
-
-
Robert W. Baird Lifts Price Target on Dendreon (DNDN) to $64 Following Provenge Approval
-
-
-
-
27,186 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

